Online consultations with MCSC doctors n. a. A. S. Loginov

Stomach cancer. MCSC patient's history

News

A young girl, starting from the 30th week of pregnancy, had complaints:nausea; epigastric pain.

  •  
  •  

Before giving birth, these symptoms were associated with the course of pregnancy, however, on the 2nd day after giving birth, the above complaints increased sharply in the patient. In addition, there was repeated vomiting.

An examination performed at the maternity hospital revealed a stomach tumor with metastatic peritoneal lesion and ascites, and a biopsy was performed. Given the serious condition, the impossibility of self-nutrition and the prevalence of the disease, on the 11th day after giving birth, the girl was transferred to the chemotherapeutic department of MCSC named after A.S. Loginov for further treatment.

Our specialists have started drug antitumor therapy. In addition, the tumor material was immediately transferred to the pathomorphological department for immunohistochemical examination.

Despite the treatment started, the patient's condition continued to deteriorate:the pain syndrome increased; the amount of fluid in the abdominal cavity increased (ascites); nausea and vomiting increased; mechanical jaundice developed; the violation of the passage of food increased.

  •  
  •  
  •  
  •  
  •  

Doctors of the department of high-tech surgery and surgical endoscopy performed percutaneous antegrade stenting of the common bile duct, which allowed to restore the outflow of bile from the liver. 

By the time the second course of chemotherapy began, the results of an immunohistochemical study were ready – protein overexpression was detected in the tumor, and therefore the targeted drug trastuzumab was added to the treatment. Already on the 3rd day after the therapy, the patient noted a significant decrease in pain syndrome and abdominal circumference in volume.

During the control examination after 4 courses of antitumor therapy, a pronounced positive trend was noted: the thickness of the tumor lesion of the stomach wall has decreased; 

  •  
  • The fluid in the abdominal cavity has almost completely disappeared; the size of the regional lymph nodes has decreased; regression of tumor changes in the peritoneum has been noted.
  •  
  •  

Currently, the patient is continuing treatment, all symptoms of the disease have regressed. Based on the results of control examinations, further treatment tactics will be determined.

It should be noted that stomach cancer ranks 8th in incidence and 2nd in the number of deaths in Russia among all oncological diseases. If a tumor is detected at an early stage, surgery, in combination with chemotherapy, in most cases leads to a complete recovery.

Dear patients, if you are concerned about unpleasant symptoms, we recommend that you consult a doctor!You can sign up for research, as well as get answers to all your questions by calling 8-495-304-30-39.

 

 

 

GBUZ Moscow Clinical Scientific Center named after Loginov MHD